Inari Medical, Inc.(NARI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NARI Inari Medical, Inc.

Not Yet Opened 12-20 16:00:00 EST

55.45

+1.04

+1.91%

盘后55.45

+0.000.00%

18:05 EST

High55.82	Low53.49	Vol2.10M
Open53.76	D1 Closing54.41	Amplitude4.28%
Mkt Cap3.25B	Tradable Cap2.96B	Total Shares58.54M
T/O116.23M	T/O Rate3.93%	Tradable Shares53.43M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"NARI","market":"US","secType":"STK","nameCN":"Inari Medical, Inc.","latestPrice":55.45,"timestamp":1734728400000,"preClose":54.41,"halted":0,"volume":2100473,"hourTrading":{"tag":"盘后","latestPrice":55.45,"preClose":55.45,"latestTime":"18:05 EST","volume":608121,"amount":33720309.8005,"timestamp":1734735957655},"delay":0,"floatShares":53432831,"shares":58544158,"eps":-1.354304,"marketStatus":"Not Yet Opened","change":1.04,"latestTime":"12-20 16:00:00 EST","open":53.76,"high":55.82,"low":53.49,"amount":116234861.62331,"amplitude":0.042823,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.354304,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1734944400000},"marketStatusCode":0,"adr":0,"listingDate":1590120000000,"exchange":"NASDAQ","adjPreClose":54.41,"preHourTrading":{"tag":"盘前","latestPrice":53.75,"preClose":54.41,"latestTime":"09:29 EST","volume":119,"amount":6397.650035,"timestamp":1734704994102},"postHourTrading":{"tag":"盘后","latestPrice":55.45,"preClose":55.45,"latestTime":"18:05 EST","volume":608121,"amount":33720309.8005,"timestamp":1734735957655},"volumeRatio":1.7539142300911608,"impliedVol":0.9589,"impliedVolPercentile":0.9603},"requestUrl":"/m/hq/s/NARI/tweets","defaultTab":"tweets","newsList":[{"id":"2492900450","title":"Inari Medical price target raised to $63 from $50 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2492900450","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492900450?lang=en_us&edition=fundamental","pubTime":"2024-12-18 20:30","pubTimestamp":1734525011,"startTime":"0","endTime":"0","summary":"Truist analyst Richard Newitter raised the firm’s price target on Inari Medical (NARI) to $63 from $50 and keeps a Hold rating on the shares as par...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inari-medical-price-target-raised-to-63-from-50-at-truist?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inari-medical-price-target-raised-to-63-from-50-at-truist?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NARI"],"gpt_icon":0},{"id":"2492616329","title":"Oppenheimer Initiates Coverage on Inari Medical With Outperform Rating, $75 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2492616329","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492616329?lang=en_us&edition=fundamental","pubTime":"2024-12-17 23:33","pubTimestamp":1734449633,"startTime":"0","endTime":"0","summary":"Inari Medical (NARI) has an average rating of overweight and mean price target of $65.86, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPY","NARI"],"gpt_icon":0},{"id":"2492952591","title":"Oppenheimer Initiates Inari Medical at Outperform With $75 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2492952591","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492952591?lang=en_us&edition=fundamental","pubTime":"2024-12-17 20:59","pubTimestamp":1734440380,"startTime":"0","endTime":"0","summary":"Oppenheimer Initiates Inari Medical at Outperform With $75 Price Target","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPY","NARI"],"gpt_icon":0},{"id":"2492640240","title":"Inari Medical initiated with an Outperform at Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2492640240","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492640240?lang=en_us&edition=fundamental","pubTime":"2024-12-17 05:11","pubTimestamp":1734383498,"startTime":"0","endTime":"0","summary":"Oppenheimer initiated coverage of Inari Medical (NARI) with an Outperform rating and $75 price target Inari is a leader in the thrombectomy for the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inari-medical-initiated-with-an-outperform-at-oppenheimer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inari-medical-initiated-with-an-outperform-at-oppenheimer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","NARI"],"gpt_icon":0},{"id":"2490815783","title":"Inari Medical Stock Gets RS Rating Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2490815783","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490815783?lang=en_us&edition=fundamental","pubTime":"2024-12-12 03:59","pubTimestamp":1733947140,"startTime":"0","endTime":"0","summary":"Inari Medical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating","market":"sg","thumbnail":"https://www.investors.com/wp-content/uploads/2017/05/IRU6-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2017/05/IRU6-150x150.jpg"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.investors.com/news/inari-medical-stock-gets-rs-rating-upgade/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["NARI","RS"],"gpt_icon":0},{"id":"2489478148","title":"Hologic (HOLX) Down 1.7% Since Last Earnings Report: Can It Rebound?","url":"https://stock-news.laohu8.com/highlight/detail?id=2489478148","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489478148?lang=en_us&edition=fundamental","pubTime":"2024-12-05 00:30","pubTimestamp":1733329850,"startTime":"0","endTime":"0","summary":"It has been about a month since the last earnings report for Hologic . Shares have lost about 1.7% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Hologic due for a breakout?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.Hologic, Inc. reported adjusted earnings per share of $1.01 in the fourth quarter of fiscal 2024, up 13.5% year over year. However, the bottom line missed the Zacks Consensus Estimate by 0.9%.The company’s GAAP earnings were 76 cents in the quarter compared with 37 cents in the year-ago period.Fiscal 2024 adjusted earnings per share was $4.08, up 3% from fiscal 2023.International revenues amounted to $242.3 million, up 5.4% year over year and up 4.3% at CER. Our model’s projection was $244.4 million.The business reported a 5.7% year-over-year  i","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9naTdeJlVMX28sdlDpLdrQ--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9naTdeJlVMX28sdlDpLdrQ--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hologic-holx-down-1-7-163050501.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HOLX","NARI"],"gpt_icon":0},{"id":"2488184381","title":"Reasons to Retain Inari Medical Stock in Your Portfolio for Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2488184381","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488184381?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:46","pubTimestamp":1733316360,"startTime":"0","endTime":"0","summary":"Inari Medical, Inc.NARI is well poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency on the adoption of its products is concerning.Shares of this Zacks Rank #3  company have lost 20.6% year to date against theindustry’s 6.4% growth. The S&P 500 Index has risen 27.1% in the same time frame.NARI, with a market capitalization of $3.05 billion, is a commercial-stage medical device company. It seeks to develop products for treating and changing the lives of patients suffering from venous diseases.The company’s negative earnings yield of 1.7% compares favorably with the industry’s . It delivered a trailing four-quarter average earnings surprise of 24.77%.Inari Medical’s top-line growth is primarily driven by its ClotTriever and FlowTriever products that target patients with venous thromboembolism  . The significant growth prospects for Inari’s VTE products should help drive the com","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/EaeP7x4PV_ZAM6p1_4R6Eg--~B/aD0zNDk7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b66321e586fa6fdc44309f696ff0a17a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/EaeP7x4PV_ZAM6p1_4R6Eg--~B/aD0zNDk7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b66321e586fa6fdc44309f696ff0a17a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/reasons-retain-inari-medical-stock-124600758.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AXGN","LU0240878834.USD","LU0390134368.USD","LU0205193047.USD","ARAY","LU0240877869.USD","NARI","LU0205194284.USD","BK4082","MASI"],"gpt_icon":0},{"id":"2488294459","title":"NARI Stock Likely to Gain Following Reimbursement Approval in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2488294459","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488294459?lang=en_us&edition=fundamental","pubTime":"2024-12-04 00:20","pubTimestamp":1733242800,"startTime":"0","endTime":"0","summary":"Inari Medical, Inc. NARI recently announced the receipt of a national reimbursement approval from the Japanese Ministry of Health, Labor and Welfare for its ClotTriever Thrombectomy System for deep vein thrombosis .NARI also entered into a distribution deal with Medikit Co. Ltd, a global medical device company, to facilitate the commercialization of the Clotriever system in Japan.Following the announcement, shares of the company closed flat at $52.12 on Monday. However, in the year-to-date period, NARI’s shares have lost 19.7% against the industry’s 6.4% growth. The S&P 500 increased 27.1% in the same time frame.More on NARI’s CloTriever System & Its Reimbursement Approval. In December, NARI unveiled that it had entered into a joint venture with 6 Dimensions Capital and its successor fund, 120 Capital, and VFLO Medical, a medical device platform incubated by 6 Dimensions and 120 Capital, to provide access to its innovative technology for patients with significant unmet needs","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Z2Y2lgbJQfUa74IVYcsxPA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Z2Y2lgbJQfUa74IVYcsxPA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nari-stock-likely-gain-following-162000278.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","LU0390134368.USD","MASI","ANGO","LU0205194284.USD","GMED","LU0240878834.USD","IE0009354923.USD","NARI","LU0240877869.USD","LU0205193047.USD","LU2065732104.USD"],"gpt_icon":0},{"id":"2488986347","title":"BRIEF-Inari Medical Announces Reimbursement Approval For Clottriever® Thrombectomy System","url":"https://stock-news.laohu8.com/highlight/detail?id=2488986347","media":"Reuters","labels":["corporation","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488986347?lang=en_us&edition=fundamental","pubTime":"2024-12-03 05:17","pubTimestamp":1733174260,"startTime":"0","endTime":"0","summary":"BRIEF-Inari Medical Announces Reimbursement Approval For Clottriever Thrombectomy SystemDec 2 (Reuters) - Inari Medical Inc NARI.O:INARI MEDICAL ANNOUNCES REIMBURSEMENT APPROVAL FOR CLOTTRIEVER THROMB","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nTUA1VSTBB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NARI","BK4082","LU0390134368.USD"],"gpt_icon":0},{"id":"2488398509","title":"BRIEF-Inari Medical Announces Joint Venture In Greater China","url":"https://stock-news.laohu8.com/highlight/detail?id=2488398509","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488398509?lang=en_us&edition=fundamental","pubTime":"2024-12-03 05:12","pubTimestamp":1733173979,"startTime":"0","endTime":"0","summary":"BRIEF-Inari Medical Announces Joint Venture In Greater ChinaDec 2 (Reuters) - Inari Medical Inc NARI.O:INARI MEDICAL ANNOUNCES JOINT VENTURE IN GREATER CHINAINARI MEDICAL INC - ENTERS JOINT VENTURE WI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nTUA2FLMKR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NARI","BK4082","LU0390134368.USD"],"gpt_icon":0},{"id":"2488985013","title":"Inari Medical Inc - Clottriever System 510(K)-Cleared by FDA and Ce-Marked for Dvt","url":"https://stock-news.laohu8.com/highlight/detail?id=2488985013","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488985013?lang=en_us&edition=fundamental","pubTime":"2024-12-03 05:06","pubTimestamp":1733173560,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nTUA1VSTBB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NARI","BK4082","LU0390134368.USD"],"gpt_icon":0},{"id":"2488898501","title":"Inari Medical Inc - Enters Distribution Agreement With Medikit Co., Ltd.","url":"https://stock-news.laohu8.com/highlight/detail?id=2488898501","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488898501?lang=en_us&edition=fundamental","pubTime":"2024-12-03 05:06","pubTimestamp":1733173560,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nTUA1VSTBB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NARI","BK4082","LU0390134368.USD"],"gpt_icon":0},{"id":"2488854189","title":"Inari Medical Announces Reimbursement Approval for Clottriever® Thrombectomy System in Japan and New Distribution Partnership With Medikit Co., Ltd.","url":"https://stock-news.laohu8.com/highlight/detail?id=2488854189","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488854189?lang=en_us&edition=fundamental","pubTime":"2024-12-03 05:06","pubTimestamp":1733173560,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nTUA1VSTBB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NARI","LU0390134368.USD"],"gpt_icon":0},{"id":"2488030985","title":"Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.","url":"https://stock-news.laohu8.com/highlight/detail?id=2488030985","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488030985?lang=en_us&edition=fundamental","pubTime":"2024-12-03 05:06","pubTimestamp":1733173560,"startTime":"0","endTime":"0","summary":"Reimbursement approval supports expanded access to effective, safe thrombus removal for patients suffering from deep vein thrombosis (DVT) in JapanIRVINE, Calif., Dec.  02, 2024  (GLOBE NEWSWIRE) -- I","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/02/2990144/0/en/Inari-Medical-Announces-Reimbursement-Approval-for-ClotTriever-Thrombectomy-System-in-Japan-and-New-Distribution-Partnership-with-Medikit-Co-Ltd.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0390134368.USD","MKCLF","WRD","BK4082","NARI"],"gpt_icon":0},{"id":"2488985497","title":"Inari Medical Inc - Enters Joint Venture With 6 Dimensions and Vflo Medical","url":"https://stock-news.laohu8.com/highlight/detail?id=2488985497","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488985497?lang=en_us&edition=fundamental","pubTime":"2024-12-03 05:05","pubTimestamp":1733173500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nTUA2FLMKR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NARI","LU0390134368.USD"],"gpt_icon":0},{"id":"2488851009","title":"Inari Medical Announces Joint Venture in Greater China","url":"https://stock-news.laohu8.com/highlight/detail?id=2488851009","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488851009?lang=en_us&edition=fundamental","pubTime":"2024-12-03 05:05","pubTimestamp":1733173500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nTUA2FLMKR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NARI","LU0390134368.USD"],"gpt_icon":0},{"id":"2488985743","title":"Inari Medical Announces Joint Venture in Greater China","url":"https://stock-news.laohu8.com/highlight/detail?id=2488985743","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488985743?lang=en_us&edition=fundamental","pubTime":"2024-12-03 05:05","pubTimestamp":1733173500,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Dec.  02, 2024  (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from ve","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/02/2990130/0/en/Inari-Medical-Announces-Joint-Venture-in-Greater-China.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0390134368.USD","BK4082","WRD","BK4185","NARI","JYNT"],"gpt_icon":0},{"id":"2487598462","title":"Why Is Penumbra (PEN) Up 6.7% Since Last Earnings Report?","url":"https://stock-news.laohu8.com/highlight/detail?id=2487598462","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487598462?lang=en_us&edition=fundamental","pubTime":"2024-11-30 00:31","pubTimestamp":1732897918,"startTime":"0","endTime":"0","summary":"A month has gone by since the last earnings report for Penumbra . Shares have added about 6.7% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Penumbra due for a pullback?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.Penumbra reported third-quarter 2024 adjusted earnings per share of 85 cents, which surpassed the Zacks Consensus Estimate by 23.2%. Adjusted earnings per share improved 26.9% year over year.Penumbra registered revenues of $301 million in the reported quarter, up 11.1% year over year on a reported basis and 10.9% at a constant exchange rate or CER. The figure topped the Zacks Consensus Estimate by 1%.Sales in the International segment dropped 1.9% to $74.7 million. Excluding the impact of foreign currency, the unit’s sales were down 2.5% year over ye","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/apbC75v0joJeGGZArvqIvw--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/apbC75v0joJeGGZArvqIvw--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-penumbra-pen-6-7-163158676.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NARI","PEN"],"gpt_icon":0},{"id":"2486720589","title":"Inari Medical Positioned for Growth: Buy Recommendation Based on Market Leadership and Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2486720589","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486720589?lang=en_us&edition=fundamental","pubTime":"2024-11-25 14:05","pubTimestamp":1732514737,"startTime":"0","endTime":"0","summary":"David Rescott, an analyst from Robert W. Baird, maintained the Buy rating on Inari Medical (NARI – Research Report). The associated price target re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/inari-medical-positioned-for-growth-buy-recommendation-based-on-market-leadership-and-innovation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/inari-medical-positioned-for-growth-buy-recommendation-based-on-market-leadership-and-innovation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XELB","BK4082","NARI","LU0390134368.USD","BK4094"],"gpt_icon":0},{"id":"2484715296","title":"Inside a $400 billion bet on the brain-computer interface revolution","url":"https://stock-news.laohu8.com/highlight/detail?id=2484715296","media":"Yahoo Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484715296?lang=en_us&edition=fundamental","pubTime":"2024-11-18 23:00","pubTimestamp":1731942057,"startTime":"0","endTime":"0","summary":"Computer chips are coming to a brain near you — and sooner than you think.At least that's according to a report by investment bank Morgan Stanley, which estimates the brain-computer interface  market could be the next opportunity for investors, with a total addressable market of $400 billion.\"This is, to us, the next big opportunity in med tech — and it's rare,\" Morgan Stanley analyst Kallum Titchmarsh told Yahoo Finance. \"BCIs have been in development for 100 years essentially. When you are five years away from full commercial launches, I think it's time to get excited and get ahead of the curve.\". \"On our numbers, we expect just under $1.5 billion of revenue to be generated from BCI implant procedures out to 2035 , and hitting the $1 billion annual run rate by 2041,\" the report said. \"To us, these numbers seem very plausible, particularly when compared to existing med tech end markets...\". Analysts told Yahoo Finance that several neuro-technology companies are vying to be the Apple  ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Kvdc4kCLc0UJUiDC7R5BMg--~B/aD0yNzgwO3c9NDAwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2024-10/f3dfdd60-a29b-11ef-bbbf-e50392a5da6b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Kvdc4kCLc0UJUiDC7R5BMg--~B/aD0yNzgwO3c9NDAwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2024-10/f3dfdd60-a29b-11ef-bbbf-e50392a5da6b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inside-a-400-billion-bet-on-the-brain-computer-interface-revolution-150057794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2092627202.USD","PEN","BK4579","LU1582987324.SGD","EMBC","PLTR","BK4516","LU1670711123.USD","LU2242649171.HKD","LU2041044095.USD","LU0057025933.USD","LU1989764748.USD","LU0158827948.USD","LU2237957811.SGD","LU2065171311.SGD","BK4573","LU1989763005.USD","SG9999014898.SGD","LU1670627923.USD","BCI","MSFT","IE00BYQQ9H92.USD","IE0034235188.USD","LU1235295455.SGD","IRTC","LU0444973449.USD","ABT","SGHT","NVRO","LU1582986433.USD","LU1221951046.USD","IE00BMPRXR70.SGD","LU1066051811.HKD","LU1201861249.SGD","NARI","IE0004445015.USD","BK4023","LU2065171402.SGD","SG9999004303.SGD","LU2028103732.USD","LU1582987597.SGD","LU0345769631.USD","MDT","LU2403377893.USD","IE00BQXX3C00.GBP","BK4576","INSP","BSX","AMZN","LU1868837300.USD","GB00B4LPDJ14.GBP","LU1035775433.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"https://www.inarimedical.com","stockEarnings":[{"period":"1week","weight":-0.0025},{"period":"1month","weight":0.1316},{"period":"3month","weight":0.2695},{"period":"6month","weight":0.2054},{"period":"1year","weight":-0.1524},{"period":"ytd","weight":-0.1459}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0403},{"period":"6month","weight":0.0857},{"period":"1year","weight":0.2506},{"period":"ytd","weight":0.2437}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.081523},{"month":2,"riseRate":0.5,"avgChangeRate":0.022055},{"month":3,"riseRate":1,"avgChangeRate":0.047729},{"month":4,"riseRate":0.5,"avgChangeRate":-0.046873},{"month":5,"riseRate":0.25,"avgChangeRate":-0.043859},{"month":6,"riseRate":0.6,"avgChangeRate":0.026515},{"month":7,"riseRate":0.4,"avgChangeRate":0.042564},{"month":8,"riseRate":0.4,"avgChangeRate":0.064666},{"month":9,"riseRate":0.2,"avgChangeRate":-0.032558},{"month":10,"riseRate":0.6,"avgChangeRate":0.047252},{"month":11,"riseRate":0.4,"avgChangeRate":-0.006485},{"month":12,"riseRate":0.8,"avgChangeRate":0.077797}],"exchange":"NASDAQ","name":"Inari Medical, Inc.","nameEN":"Inari Medical, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inari Medical, Inc.(NARI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Inari Medical, Inc.(NARI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Inari Medical, Inc.,NARI,Inari Medical, Inc.股票,Inari Medical, Inc.股票老虎,Inari Medical, Inc.股票老虎国际,Inari Medical, Inc.行情,Inari Medical, Inc.股票行情,Inari Medical, Inc.股价,Inari Medical, Inc.股市,Inari Medical, Inc.股票价格,Inari Medical, Inc.股票交易,Inari Medical, Inc.股票购买,Inari Medical, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inari Medical, Inc.(NARI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Inari Medical, Inc.(NARI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction